August 3, 2019
$10 million in 10 years
Tau Kappa Epsilon makes the largest commitment by any men's fraternity to St. Jude Children's Research Hospital
“It is a great honor to share with you our next step in helping to achieve Frater Danny Thomas’s dream that ‘no child should die in the dawn of life.’ Today, we make history. Today, we dedicate ourselves to building a better world by making the largest commitment by any men’s fraternity to St. Jude Children’s Research Hospital. Today, we officially begin our campaign to raise $10 million over the next ten years for the children of St. Jude,” stated Hanson.
Tau Kappa Epsilon (TKE) fraternity and St. Jude Children's Research Hospital® announced a commitment to raise $10 million for St. Jude within the next 10 years, which will be recognized by the naming of the hospital's Bone Marrow Transplantation & Cellular Therapy Research floor.
This new iteration of fundraising was announced at Conclave, the fraternity's biennial celebration, and marks the third commitment TKE has made to the hospital since the fraternity officially began its partnership with St. Jude in 1972.
In 2011 TKE pledged to raise $1 million in five years towards the naming of an MRI suite in the Chili's Care Center on the St. Jude campus, which TKE met this goal a year early. Then in 2016, TKE pledged to raise $2.6 million for the hospital toward the naming of the proton therapy synchrotron/particle accelerator.
Support from partners like TKE and donors worldwide help ensure families never receive a bill from St. Jude for treatment, travel, housing or food – because all a family should worry about is helping their child live. St. Jude freely shares the discoveries it makes, and every child saved at St. Jude means doctors and scientists worldwide can use that knowledge to save thousands more children.
"Since Tau Kappa Epsilon first answered our Founder Danny Thomas' call for support more than 30 years ago, the fraternity has positively impacted countless events and programs to help live out Danny's dream that 'no child should die in the dawn of life,'" said Richard Shadyac Jr., President and CEO of ALSAC, the fundraising and awareness organization for St. Jude Children's Research Hospital. "The naming of the Bone Marrow Transplantation & Cellular Therapy Research floor is testament to the dedication of TKE and St. Jude to positively impacting the lives of children worldwide."
To learn more about the partnership between St. Jude and Tau Kappa Epsilon, visit stjude.org/tke
. Make a Gift In Support of This Commitment